NX
LIVE

Serial Number

79393467

Owner

Andrea Jacobs

Attorney

Nicholas D. Wells

Filing Date

Feb 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NX Trademark

Serial Number: 79393467 • Registration: 7862423

NX is a trademark filed by Andrea Jacobs on February 15, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Andrea Jacobs (2 trademarks)

Zelghalde 8

Entity Type: 98

Navignostics AG (3 trademarks)

c/o Andrea Jacobs,

Entity Type: 25

Trademark Details

Filing Date

February 15, 2024

Registration Date

July 15, 2025

Published for Opposition

May 27, 2025

Goods & Services

Pharmaceutical and medical consulting, particularly in the field of medical diagnostics and oncology; pharmaceutical and medical consulting for businesses in the medical and medical diagnostics field; pharmaceutical and medical consulting for cancer treatment; disease diagnosis services; cancer diagnosis services, particularly for enabling personalized and individual medical care; disease diagnosis services, particularly in the field of oncology; disease diagnosis services in the field of proteomics; medical analysis services for cancer diagnosis and prognosis; remote monitoring of medical data for medical diagnosis; medical analysis for the diagnosis and treatment of persons; remote monitoring of medical data for medical diagnosis and treatment; medical testing services relating to the diagnosis and treatment of disease; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical diagnosis and treatment of cancer; testing and analysis services being medical diagnostic services; medical diagnostic services for the indication of individual treatments; medical diagnostic services for the indication of individual cancer treatments; medical diagnostic services for the indication of individual treatments in the field of oncology; providing information concerning diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological products for prevention and treatment of diseases, disorders and conditions; medical services; veterinary services; hygienic care for human beings; hygienic care for animals

Recorded computer programs for use in oncology for analysing tissue samples from patients; downloadable computer programs for use in oncology for analysing tissue samples from patients; downloadable software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; downloadable software for the digital representation of tumors and tumor features; software for the digital representation of tumors and tumor features; downloadable software for high- resolution digital image representation of the molecular composition of cellular anomalies; recorded software for high-resolution digital image representation of the molecular composition of cellular anomalies; downloadable software for high- resolution digital image representation of a digital tumor; recorded software for high- resolution digital image representation of a digital tumor; downloadable software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; recorded software for the analysis of medical data, particularly for cancer research, treatment and diagnosis

Diagnostic preparations for medical purposes; diagnostic radiopharmaceutical preparations for medical purposes; pharmaceutical products, medical and veterinary preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for the diagnosis and treatment of cancer; diagnostic pharmaceutical preparations; medical test kits comprising pharmaceutical preparations for individual medical diagnosis for cancer therapy; medical test kits comprising pharmaceutical preparations for use in oncology for cancer screening; medical test kits comprising pharmaceutical preparations for cancer diagnosis; medical test kits comprising pharmaceutical preparations for individual medical diagnosis in the field of protein imaging; Diagnostic test kits for use in oncology comprising pathology slides for testing tissue samples; test kits for use in oncology comprising sample tubes for testing tissue samples; diagnostic test kits comprising laboratory equipment for sample preparation, processing and storage for cancer diagnosis; diagnostic test kits for individual medical diagnosis comprising sample collection equipment for tumour analysis

Medical research in the field of cancer; medical research in the field of cancer diagnosis; Medical research in the field of proteomics; Medical research in the field of oncology; Medical research in the field of oncological diagnostics; technical data analysis services, namely, medical data analysis for cancer diagnostics; software-as-a-service (SaaS) featuring software for use in cancer diagnosis; platform-as-a-service (PaaS) featuring software for use in cancer diagnosis; software-as-a-service (SaaS) featuring software for cell analysis for use in oncology; platform-as-a-service (PaaS) featuring software for cell analysis for use in oncology; software-as-a-service (SaaS) featuring software for medical and scientific research in the field of cancer treatment and diagnosis; platform-as-a-service (PaaS) featuring software for medical and scientific research in the field of cancer treatment and diagnosis; software-as-a-service (SaaS) featuring software using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; Platform as- a-service (PaaS) featuring software using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; software-as-a-service (SaaS) featuring software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; platform-as-a-service (PaaS) featuring software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; software as-a-service (SaaS) featuring software for the digital representation of tumours and tumour features; platform-as-a-service (PaaS) featuring software for the digital representation of tumours and tumour features; software as-a-service (SaaS) featuring software for high- resolution digital image representation of the molecular composition of cellular anomalies; platform-as-a-service (PaaS) featuring software for high-resolution digital image representation of the molecular composition of cellular anomalies; software as-a-service (SaaS) featuring software for high- resolution digital image representation of digital tumors; platform-as-a-service (PaaS) featuring software for high- resolution digital image representation of digital tumors

Diagnostic biomarkers for analytical, research and scientific use; diagnostic biomarkers for in vitro testing for scientific use; diagnostic biomarkers for use in assessment of genomic analysis for scientific use; diagnostic biomarkers for use in assessment of individual diagnoses of cancer; diagnostic preparations for science or research; diagnostic reagents for science or research diagnostic reagents for the diagnosis of diseases; chemicals for the production of medical diagnostic reagents, particularly for cancer research

Apparatus for tumour diagnosis, namely, Imaging Mass Cytometry (IMC) apparatus; medical apparatus, namely, spectrometers for machine learning-based spectrum analysis of human blood plasma; Multiplex protein imaging scanners for medical diagnosis; apparatus for clinical diagnosis, namely, digital imaging device; spectrum analyzers for use in medical diagnosis; apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteins, namely, spatial proteomics tools; diagnostic oncology apparatus for medical use, namely, digital imaging device; diagnostic, examination, and monitoring equipment, namely, multiplex protein imaging equipment; medical test kits comprising tissue sampling equipment for the use in oncology for cancer screening; medical test kits comprising tissue analysis tools for individual diagnosis in the field of cancer therapy

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 26, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 5, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 15, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 27, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 10, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 15, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 21, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 26, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 4, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 4, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 1, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 30, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2024 DOCK
CHANGE OF OWNER RECEIVED FROM IB
Jul 6, 2024 CHLD
APPLICATION FILING RECEIPT MAILED
Apr 18, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2024 REPR